Leadership:

Technology Board



Our Technology Board is comprised of an extraordinary assembly of leaders who provide guidance in advancing our research portfolio.

Kenneth C. Anderson, MD, PhD

Chairman, MMRF Technology Board
Chief, Division of Hematologic Neoplasia
Director, James Lipper Multiple Myeloma Center
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
www.dfci.harvard.edu

Bart Barlogie, MD, PhD

Professor of Medicine and Pathology
Director, Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, AR
www.myeloma.uams.edu

Richard Caprioli, PhD

Stanley Cohen Professor of Biochemistry
Director of the Mass Spectrometry Research Center
Vanderbilt University School of Medicine
Nashville, TN
www.vanderbilt.edu

Arul Chinnaiyan, MD, PhD

S.P. Hicks Endowed Professor of Pathology and Urology,
Director of Pathology Research Informatics
Director of Cancer Bioinformatics
University of Michigan
Ann Arbor, MI
www.umich.edu

William Dalton, PhD, MD

Chief Executive Officer
Center Director
H Lee Moffitt Cancer Center and Research Institute
Tampa, FL
www.moffitt.usf.edu

Nicholas Dracopoli, PhD

Vice President, Biomarkers
Centocor Research and Development, Inc.
Johnson & Johnson
Radnor, PA
www.centocor.com

Ellen Feigal, MD

Executive Medical Director
Global Development
Amgen, Inc.
Thousand Oaks, CA
www.amgen.com


Daniel Von Hoff, MD

Director
Clinical Translational Research Division
TGen
Phoenix, AZ
www.tgen.org

Carl June, MD

Professor and Director, Translational Research
Department of Pathology and Laboratory Medicine
University of Pennsylvania
Philadelphia, PA
www.upenn.edu

David Parkinson, MD

Board Member
Clinical Advisory Board Head
Interim Chief Medical Officer
Zyngenia, Inc.
Gaithersburg, MD
www.zyngenia.com

G. David Roodman, MD, PhD

Professor of Medicine
Vice Chair for Research
Director, Myeloma Program at UPMC
University of Pittsburgh
Pittsburgh, PA
www.upmc.edu

Louis M. Staudt, MD, PhD

Chief, Lymphoidic Malignancies Section
Metabolism Branch, Center for Cancer Research
National Cancer Institute
Bethesda, MD
www.ccr.cancer.gov

Freda K. Stevenson, MSc, Dphil, FRCP

Professor
University of Southampton School of Medicine
Southampton, United Kingdom
www.som.soton.ac.uk

Richard Wahl, MD

Professor of Radiology and Oncology
Director, Division of Nuclear Medicine
Russell H. Morgan Department of Radiology and Radiological Science
Johns Hopkins University
Baltimore, MD
www.jhmi.edu